title: Light responses and morphology of bNOS-immunoreactive neurons in the mouse retina.
abstract: Nitric oxide (NO), produced by NO synthase (NOS), modulates the function of all retinal neurons and ocular blood vessels and participates in the pathogenesis of ocular diseases. To further understand the regulation of ocular NO release, we systematically studied the morphology, topography, and light responses of NOS-containing amacrine cells (NOACs) in dark-adapted mouse retina. Immunohistological staining for neuronal NOS (bNOS), combined with retrograde labeling of ganglion cells (GCs) with Neurobiotin (NB, a gap junction permeable dye) and Lucifer yellow (LY, a less permeable dye), was used to identify NOACs. The light responses of ACs were recorded under whole-cell voltage clamp conditions and cell morphology was examined with a confocal microscope. We found that in dark-adapted conditions bNOS-immunoreactivity (IR) was present primarily in the inner nuclear layer and the ganglion cell layer. bNOS-IR somas were negative for LY, thus they were identified as ACs; nearly 6% of the cells were labeled by NB but not by LY, indicating that they were dye-coupled with GCs. Three morphological subtypes of NOACs (NI, NII, and displaced) were identified. The cell density, intercellular distance, and the distribution of NOACs were studied in whole retinas. Light evoked depolarizing highly sensitive ON-OFF responses in NI cells and less sensitive OFF responses in NII cells. Frequent (1-2 Hz) or abrupt change of light intensity evoked larger peak responses. The possibility for light to modify NO release from NOACs is discussed.
authors.affiliation: Department of Ophthalmology, Baylor College of Medicine, Houston, Texas 77030, USA. jpang@bcm.tmc.edu
authors.forename: Ji-Jie
authors.initials: JJ
authors.lastname: Pang
authors.forename: Fan
authors.initials: F
authors.lastname: Gao
authors.forename: Samuel M
authors.initials: SM
authors.lastname: Wu
mesh_terms: D000221:Adaptation, Ocular / Q000187:drug effects / Q000502:physiology; D025042:Amacrine Cells / Q000166:cytology* / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D002452:Cell Count; D003624:Darkness; D005074:Evoked Potentials, Visual / Q000187:drug effects; D005260:Female; D066298:In Vitro Techniques; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D052248:Nitric Oxide Synthase Type I / Q000235:genetics / Q000378:metabolism*; D010775:Photic Stimulation; D018091:Receptors, AMPA / Q000378:metabolism; D018092:Kainic Acid Receptors / Q000378:metabolism; D012160:Retina / Q000166:cytology* / Q000187:drug effects / Q000502:physiology*; D014785:Vision, Ocular / Q000187:drug effects / Q000502:physiology*
chemical_list: D052248:Nitric Oxide Synthase Type I; D018091:Receptors, AMPA; D018092:Kainic Acid Receptors; C496321:Nos1 protein, mouse